Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion R Wofford

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|December 8, 2004
Pathophysiology and treatment of obesity hypertensionMarion R Wofford, John E Hall
Current Hypertension Reports|September 10, 2009
Hypertension: issues in control and resistanceMarion R Wofford, Deborah S Minor
Metabolic Syndrome and Related Disorders|March 29, 2008
Relationship between antihypertensive drugs and metabolic syndromeMarion R Wofford, Deborah S King
Hypertension (Dallas, Tex. : 1979)|December 25, 2018
Prevalence of Apparent Treatment-Resistant HypertensionDaniel W Jones, Donald Clark, Marion R Wofford
Current Hypertension Reports|May 14, 2008
The treatment of hypertension in obese patientsMarion R Wofford, Grant Smith, Deborah S Minor
Journal of Clinical Hypertension (Greenwich, Conn.)|February 14, 2006
Drug-induced metabolic syndromeMarion R Wofford, Deborah S King, T Kristopher Harrell
Journal of the Mississippi State Medical Association|October 26, 2012
Top 10 facts you should know about diabetesRosemary J Call, Marion R Wofford, Daniel M Riche
Current Atherosclerosis Reports|April 18, 2008
Racial and ethnic differences in hypertensionDeborah S Minor, Marion R Wofford, Daniel W Jones
The American Journal of the Medical Sciences|December 13, 2003
Does it matter how we lower blood pressure?Jimmy Stewart, Marion R Wofford, Deborah S King, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 31, 2007
Hepatocellular necrosis associated with labetalolR Craig Long, Marion R Wofford, Kimberly G Harkins, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|December 8, 2004
Pathophysiology and treatment of obesity hypertensionMarion R Wofford, John E Hall
Current Hypertension Reports|September 10, 2009
Hypertension: issues in control and resistanceMarion R Wofford, Deborah S Minor
Metabolic Syndrome and Related Disorders|March 29, 2008
Relationship between antihypertensive drugs and metabolic syndromeMarion R Wofford, Deborah S King
Hypertension (Dallas, Tex. : 1979)|December 25, 2018
Prevalence of Apparent Treatment-Resistant HypertensionDaniel W Jones, Donald Clark, Marion R Wofford
Current Hypertension Reports|May 14, 2008
The treatment of hypertension in obese patientsMarion R Wofford, Grant Smith, Deborah S Minor
Journal of Clinical Hypertension (Greenwich, Conn.)|February 14, 2006
Drug-induced metabolic syndromeMarion R Wofford, Deborah S King, T Kristopher Harrell
Journal of the Mississippi State Medical Association|October 26, 2012
Top 10 facts you should know about diabetesRosemary J Call, Marion R Wofford, Daniel M Riche
Current Atherosclerosis Reports|April 18, 2008
Racial and ethnic differences in hypertensionDeborah S Minor, Marion R Wofford, Daniel W Jones
The American Journal of the Medical Sciences|December 13, 2003
Does it matter how we lower blood pressure?Jimmy Stewart, Marion R Wofford, Deborah S King, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 31, 2007
Hepatocellular necrosis associated with labetalolR Craig Long, Marion R Wofford, Kimberly G Harkins, et al.
Pageof 3